EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

L26/P-426 Fertility preservation and reproductive outcomes in females with haemoglobinopathies: a systematic review and meta-analysis

K. Sherlock, W. Pun, P. Eleftheriou, B. Carpenter, B. Hylton, S. Lavery, M. Davies, E. Yasmin

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.760 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von K. Sherlock und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question What are the reproductive health implications and fertility preservation practices in females with haemoglobinopathies, and how can evidence inform safe, timely, condition-specific fertility preservation? Summary answer Haemoglobinopathy curative transplantation and conditioning confer near-universal ovarian failure; safe fertility preservation is feasible with standardised multidisciplinary pathways, mandating early referral to protect reproductive autonomy. What is known already Approximately 7% of the global population carry haemoglobinopathy traits, disproportionately affecting specific ethnic groups, yet fertility preservation (FP) evidence remains limited relative to disease burden, particularly regarding safety and reproductive outcomes. Haemopoietic stem cell transplant (HSCT) and emerging gene-editing therapies offer curative treatment strategies for sickle cell disease (SCD) and transfusion dependent thalassaemia (TDT) but require ablative treatment with substantial gonadotoxic impact. Therefore, the performance of fertility preservation (FP) is key for safer future pregnancy, but the sequelae of haemoglobinopathies denote known and significant challenges to FP success, including vaso-occlusive crises, iron overload, thrombotic risk, transfusion requirement and anaesthetic complexity. Study design, size, duration This study is a systematic review and meta-analysis of published literature examining reproductive and FP outcomes in females with haemoglobinopathies. Searches were conducted across nine electronic databases from inception to 3 November 2025. After deduplication, 1,256 records were screened, 324 full texts assessed, and 84 studies met the inclusion criteria of female haemoglobinopathy and reproductive or FP outcomes. Participants/materials, setting, methods Participants included females of any age, pre or post pubertal, with haemoglobinopathies undergoing assessment of fertility, reproductive health, or fertility preservation. Two reviewers independently screened studies and extracted data on disease characteristics, treatment exposures, fertility preservation indication and modality, storage and return-to-use, reproductive and endocrine outcomes, and complications. Risk of bias was assessed using tools appropriate to study design. Random-effects meta-analysis or meta-synthesis was performed where feasible. Main results and the role of chance A total of 84 international studies met inclusion criteria, reporting reproductive outcomes or fertility preservation (FP) in females with sickle cell disease (SCD) or transfusion-dependent thalassaemia (TDT), published between 2006 and 2025, with over half since 2021. Two retrospective cohort studies described 33 controlled ovarian stimulation (COS) cycles (SCD 22/33; TDT 9/33; ages 11–33 years), demonstrating successful oocyte retrieval in almost all cases, with one mild ovarian hyperstimulation syndrome event. One additional cohort reported uncomplicated ovarian tissue cryopreservation (OTC) in 75 pre-pubertal patients with SCD (ages 10–14 years). Twenty-eight studies contributed small case reports or series of individual FP attempts, while 52 provided contextual data on reproductive health, counselling, or service delivery. When FP was offered, uptake and completion were consistently high. Pre-pubertal patients underwent OTC exclusively, with near-universal procedural completion: among those returning to use, ovarian endocrine recovery (n = 17) and pregnancies (n = 24) were reported. Post-menarche patients predominantly underwent COS with oocyte cryopreservation. COS completion exceeded 90%; however, 3–5% discontinued due to complications, including vaso-occlusive crises and acute chest syndrome in SCD. Consistently reported barriers included delayed referral, missing the window of optimal ovarian reserve, logistical and transfusion planning challenges, and procedure-related risks of thrombosis, vaso-occlusion, and respiratory compromise. Limitations, reasons for caution Searches were limited to human studies published in English. Risk of bias was assessed using study-design–appropriate tools. The evidence base is dominated by small samples and low quality evidence. The evaluated literature focused on FP uptake, completion, and complications; reproductive outcomes were insufficiently reported. Wider implications of the findings FP for females with haemoglobinopathies facing curative treatment is feasible, safe, rarely delays treatment, and valid as gonadotoxic conditioning confers high infertility risk. However, this patient group have unique medical challenges. Early referral and integrated, multidisciplinary pathways are essential to improve FP outcome, equity, safety, and long-term reproductive autonomy. Trial registration number Yes

Zitieren

APA

Sherlock, K., Pun, W., Eleftheriou, P., Carpenter, B., Hylton, B., Lavery, S., Davies, M., & Yasmin, E. (2026). L26/P-426 Fertility preservation and reproductive outcomes in females with haemoglobinopathies: a systematic review and meta-analysis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.760

Vancouver

Sherlock K, Pun W, Eleftheriou P, Carpenter B, Hylton B, Lavery S, et al. L26/P-426 Fertility preservation and reproductive outcomes in females with haemoglobinopathies: a systematic review and meta-analysis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.760

BibTeX
@article{Sherlock2026,
  author = {Sherlock, K. and Pun, W. and Eleftheriou, P. and Carpenter, B. and Hylton, B. and Lavery, S. and Davies, M. and Yasmin, E.},
  title = {L26/P-426 Fertility preservation and reproductive outcomes in females with haemoglobinopathies: a systematic review and meta-analysis},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.760}
}
Kostenlos starten →